small thoracolumbar vertebrae with anterior tonguing (Fig. 1D) , short odontoid peg, cervical platyspondyly and broad ribs, compatible with an LSD. Biochemical screening revealed low a-fucosidase in white blood cells (0.4 nmol/h/mg; normal 25-156 nmol/h/mg) and low plasma a-fucosidase (17 nmol/h/mg; normal 175-1403 nmol/h/mg). Next-generation sequencing of FUCA1 revealed compound heterozygous mutations: c.750C>A, p.Tyr*, leading to premature truncation of the FUCA1 protein; and c.1399_*15del, p.(*467Lysext*73), which disrupts the FUCA1 termination codon and extends the protein by 73 amino acids. This genotype was therefore confirmatory of fucosidosis.
Fucosidosis is a rare autosomal recessive LSD caused by bi-allelic mutations in FUCA1 [1] , resulting in deficiency of the a-L-fucosidase enzyme and the secretion of fucosyl-oligosaccharides [2] . The defective enzyme cannot lyse fucose-containing glycol-conjugates, leading to the intracellular accumulation of fucose in tissues [3] . Clinical features include progressive psychomotor retardation, coarse facies, growth retardation, recurrent infections, dysostosis multiplex, angiokeratoma, visceromegaly and seizures [4] . Fucosidosis has been classified into types I and II, depending on the severity of the clinical phenotype, but the disorder is now more commonly considered as a continuous clinical spectrum with variable severity of phenotype [4] .
Absence of key clinical hallmarks of fucosidosis, such as angiokeratoma and visceromegaly, early absence of coarse facies, predominance of features compatible with JIA (joint swelling, synovitis and ANA positivity) and a negative urinary oligosaccharide screen contributed to diagnostic delay in our patient. To the best of our knowledge, this is the first case report of fucosidosis presenting as JIA. Although it is possible that there was dual pathology (i.e. polyarticular JIA and fucosidosis), it is more likely that the whole phenotype is entirely explained by fucosidosis, with a secondary antiinflammatory effect of tocilizumab for destructive joint disease in that context.
It has been suggested that clinical screening by clinical examination looking for the presence of joint contractures, combined with urinary GAG analysis and other routine laboratory measures such as ESR and ANA, might differentiate mucopolysaccharidoses from JIA [5] . This approach would have failed to distinguish JIA from fucosidosis in this case, because the patient did not have joint contractures, did have elevated ESR and positive ANA, and had negative urine screening for GAG. Therefore, clinicians must remain ever vigilant to the possibility of LSD mimicking JIA, particularly if clinical trajectories are unexpectedly poor despite DMARDs
Key message
Fucosidosis is an exceptionally rare lysosomal storage disease, which can mimic JIA.
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V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com and biologics. Furthermore, a negative urinary oligosaccharide screen, attributed in this case to the clinical phenotype being at the attenuated end of the spectrum, does not exclude a diagnosis of LSD. Therefore, we add fucosidosis as an important but rare differential diagnosis for JIA, emphasizing that urinary screening of GAG does not detect this rare LSD, which requires specific lysosomal storage enzyme analysis in plasma and leucocytes, followed by genetic screening for FUCA1 mutations. Unfortunately, there is no specific treatment for fucosidosis.
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